Clinical Trial Update: AC vs TC in Patients With HR-positive, HER2-negative Early Breast Cancer [Phase 4]

View source ↗

Summary

Phase 4 trial update comparing AC vs TC in HR-positive, HER2-negative early breast cancer; status and results are currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• AC
• TC

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Breast Cancer, Chemotherapeutic Toxicity | Phase 4 | Status: UNKNOWN